Search results
Results from the WOW.Com Content Network
A review in the Journal of the American Medical Association stated "Zimmer and Morgan provide an extraordinarily well-researched and passionately argued book on the biomedical and sociological issues raised in today's debate about marijuana. In their desire to 'set the record straight', however, they sometimes sacrifice even-handedness for impact."
Research on the medical benefits of cannabis has been hindered by various federal regulations, including its Schedule I classification. [3] To conduct research on cannabis, approval must be obtained from the Food and Drug Administration, [4] and a license must be obtained from the Drug Enforcement Administration specific to Schedule I drugs. [5]
D’Souza added that cannabis use can have serious impacts on the developing brain because of its effects on the endocannabinoid system, a complex signaling system in the brain that marijuana targets.
Over time, the marijuana gateway hypothesis has been studied more and more. In one published study, the use of marijuana was shown not a reliable gateway cause of illicit drug use. [67] However, social factors and environment influence drug use and abuse, making the gateway effects of cannabis different for those in differing social circumstances.
Many studies have demonstrated various medical benefits and also that marijuana is far from a harmless drug. It’s not my intention revisit these subjects now. Public opinion drives public policy.
Now, these benefits are by no means tried and true — there's still a lot of research to be done on the actual benefits of marijuana — but they are ripe for future study. First up, cancer.
In the United States, health insurance companies may not pay for a medical marijuana prescription as the Food and Drug Administration must approve any substance for medicinal purposes. Before this can happen, the FDA must first permit the study of the medical benefits and drawbacks of the substance, which it has not done since it was placed on ...
According to Business Insider, only 6% of studies on marijuana focused on the drug's benefits. But there are so many.